Sign In
Buy BSEM
$4.14
-0.0290 (-0.696%)
At Close: Jun 03, 2026
BioStem Technologies Appoints Brandon Poe as Chief Financial Officer
04:01pm, Thursday, 14'th Aug 2025
POMPANO BEACH, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (“BioStem” or the “Company”) (OTC: BSEM), a leading MedTech company focused on the development, manufacturing,
BioStem Technologies to Host Second Quarter 2025 Financial Results Conference Call on August 14, 2025
07:00am, Wednesday, 30'th Jul 2025
Conference call and webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., July 29, 2025 – PRISM MediaWire – BioStem Technologies Inc.
BioStem Technologies Provides Comments on CMS CY 2026 Proposed Medicare Reimbursement Rule Changes for Skin Substitutes
12:37pm, Thursday, 17'th Jul 2025
The Company welcomes CMS' efforts to reform skin substitute payment policy and will continue to engage with CMS and other stakeholders to optimize the proposed changes POMPANO BEACH, Fla., July 17, 20
BioStem Technologies Provides Comments on CMS CY 2026 Proposed Medicare Reimbursement Rule Changes for Skin Substitutes
07:00am, Thursday, 17'th Jul 2025
POMPANO BEACH, Fla., July 17, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-d
BioStem Technologies to Present at the Advanced Wound Care Summit in Boston on July 15, 2025, at 2:00 PM ET
09:36am, Thursday, 10'th Jul 2025
Jason Matuszewski, Chairman and CEO, to present BioStem's current position in the chronic wound care market and key opportunities for growth POMPANO BEACH, Fla., July 10, 2025 – PRISM MediaWire –
BioStem Technologies to Present at the Advanced Wound Care Summit in Boston on July 15, 2025, at 2:00 PM ET
08:54am, Thursday, 10'th Jul 2025
POMPANO BEACH, Fla., July 10, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-d
Head-to-head study comparing BioREtain®– processed Amnion Chorion (BR-AC) allograft to standard of care initiated in Q4 2024 to demonstrate healing superiority Topline results and full data analysi
Head-to-head study comparing BioREtain ® - processed Amnion Chorion (BR-AC) allograft to standard of care initiated in Q4 2024 to demonstrate healing superiority Topline results and full data analysi
Award celebrates bold leaders shaping the future through the world's most ground-breaking companies POMPANO BEACH, Fla., June 17, 2025 – PRISM MediaWire – Ernst & Young LLP (EY US) announced that
BioStem Technologies: Huge Growth, Poised To Help Wound Care Field
07:10am, Sunday, 08'th Jun 2025
BioStem Technologies is a buy due to strong YoY growth, profitability, and undervaluation versus sector peers despite recent Q1 misses. Their advanced wound care products, powered by proprietary BioRE
BioStem Technologies Provides Update on the Company's Form 10 Submission and SEC Review Process
07:00am, Tuesday, 03'rd Jun 2025
Upon SEC approval of the amended Form 10, BioStem expects to advance its uplisting to Nasdaq POMPANO BEACH, Fla., June 3, 2025 – PRISM MediaWire – BioStem Technologies, Inc.
BioStem Technologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
07:02am, Thursday, 29'th May 2025
POMPANO BEACH, Fla., May 29, 2025 – PRISM MediaWire – BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of pla
BioStem Announces Notice of Allowance for Three New U.S. Patent Applications
07:05am, Wednesday, 28'th May 2025
Expanding patent portfolio reinforces the Company's commitment to wound care innovation, with 55 issued patents and 52 pending applications POMPANO BEACH, Fla., May 28, 2025 – PRISM MediaWire – B
Entrepreneur Of The Year celebrates ambitious entrepreneurs who are shaping the future POMPANO BEACH, Fla., May 22, 2025 – PRISM MediaWire – BioStem Technologies, Inc.
POMPANO BEACH, Fla., May 22, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (the “Company” or “BioStem”), a leading MedTech company focused on the development, manufacturing,
